Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey.

Previous research supports an association between hepatitis C virus (HCV) infection and glomerulonephritis. However, little is known about the association between HCV and chronic kidney disease. The cross-sectional association between prevalent hepatitis C seropositivity and albuminuria and estimated GFR (eGFR), respectively, was examined among 15,029 participants in the Third National Health and Nutrition Examination Survey (NHANES III). In the multivariate analysis, we noted an age-dependent association between HCV seropositivity and albuminuria (adjusted odds ratios and 95% confidence intervals 0.83, 0.39 to 1.75 for ages 20 to 39; 1.84, 1.00 to 3.37 for ages 40 to 59; 2.47, 1.27 to 4.80 for > or =60 yr of age). There was no significant association observed for hepatitis C seropositivity and low eGFR (<60 ml/min per 1.73 m(2); adjusted odds ratios and 95% confidence interval for all ages 0.89, 0.49 to 1.62). Among a representative sample of the US population, hepatitis C is independently associated with albuminuria among adults over the age of 40; however, it does not seem to be significantly associated with a low eGFR in this population-based cross-sectional analysis.

[1]  N. Accortt,et al.  Hepatitis C infection is acquired pre-ESRD. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  Charles E. McCulloch,et al.  Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models , 2005 .

[3]  N. Chalasani,et al.  Relationship between hepatitis C and microalbuminuria: results from the NHANES III. , 2005, Kidney international.

[4]  F. Bianchi,et al.  Sirolimus eluting stent aborted recurrent distal left main in-stent restenosis involving bifurcation , 2004, Heart.

[5]  E. Tuzcu,et al.  Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  G. Klintmalm,et al.  Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  R. MacIsaac,et al.  New insights into the significance of microalbuminuria , 2004, Current opinion in nephrology and hypertension.

[8]  M. Jadoul,et al.  Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. , 2003, Kidney international.

[9]  D. Riley,et al.  Prediction of GFR in liver transplant candidates. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  Ethan M Balk,et al.  Erratum: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification (Annals of Internal Medicine (2003) 139 (137-147)) , 2003 .

[11]  J. Hoofnagle,et al.  Hepatitis C and renal disease: an update. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[13]  J. Pankow,et al.  Hepatitis C virus infection and incident type 2 diabetes , 2003, Hepatology.

[14]  T. Yoshikawa,et al.  Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. , 2003, JAMA.

[15]  R. Testa,et al.  Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. , 2003, Archives of internal medicine.

[16]  H. El‐Serag,et al.  Extrahepatic manifestations of hepatitis C among United States male veterans , 2002, Hepatology.

[17]  Tom Greene,et al.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  G. Curhan,et al.  Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. , 2002, Journal of the American Society of Nephrology : JASN.

[19]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  R. Nagai,et al.  Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening , 2002, The Lancet.

[21]  T. Ahuja,et al.  Prevalence of Glomerulopathies in Autopsies of Patients Infected with the Hepatitis C Virus , 2001, The American journal of the medical sciences.

[22]  M. Szklo,et al.  Prevalence of Type 2 Diabetes Mellitus among Persons with Hepatitis C Virus Infection in the United States , 2000, Annals of Internal Medicine.

[23]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.

[24]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[25]  C. Pomeroy,et al.  Renal manifestations of hepatitis C infection. , 1999, The American journal of medicine.

[26]  C. Alpers,et al.  Focal Segmental Glomerular Sclerosis among Patients Infected with Hepatitis C Virus , 1999, Nephron.

[27]  F. Locatelli,et al.  Nephrology Dialysis Transplantation Hepatitis C Virus Infection and Acute or Chronic Glomerulonephritis: an Epidemiological and Clinical Appraisal , 2022 .

[28]  J. M. Calvo Romero,et al.  Gastric adenocarcinoma and kidney transplantation , 1998 .

[29]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[30]  F. Locatelli,et al.  Serologic survey for control of hepatitis C in haemodialysis patients: third-generation assays and analysis of costs. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  G. Dunn.  Complex surveys. , 1996, Statistical methods in medical research.

[32]  S. Chopra,et al.  Hepatitis C: A Multifaceted Disease: Review of Extrahepatic Manifestations , 1995, Annals of Internal Medicine.

[33]  C. Alpers,et al.  Hepatitis C virus associated membranous glomerulonephritis. , 1995, Clinical nephrology.

[34]  D. Gretch,et al.  Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. , 1995, Journal of the American Society of Nephrology : JASN.

[35]  C. Alpers,et al.  Renal manifestations of hepatitis C virus infection. , 1994, Kidney international.

[36]  P. Kimmel,et al.  Epidemiology of hepatitis C virus infection in patients with renal disease. , 1994, Journal of the American Society of Nephrology : JASN.

[37]  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. , 1994, Vital and health statistics. Ser. 1, Programs and collection procedures.

[38]  R. Rodby,et al.  Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. , 1993, Journal of the American Society of Nephrology : JASN.

[39]  B. Kasiske.  Risk factors for cardiovascular disease after renal transplantation. , 1993, Mineral and electrolyte metabolism.

[40]  K. Maurer,et al.  Sample design: Third National Health and Nutrition Examination Survey. , 1992, Vital and health statistics. Series 2, Data evaluation and methods research.